NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
07/05/2026
Voltar para busca
Dado oficial do USPTO
BLUE EARTH
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
BLUE EARTH
ST13
US500000086538705Classe
1, 5, 42, 44
Pedido
86538705
Registro
4925242
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
30
Atualização mais recente
26/05/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 42, 44
Data de depósito
18/02/2015
Data de registro
29/03/2016
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
07/05/2026
Última transação
26/05/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
800
Cadastro oficial
Principal Register
Fundamento do pedido
Foreign priority
Código do desenho
4
Tipo de titular
99
Localização do titular
Oxford, GB
Examinador
HELLMAN, ELI J
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Blue Earth Diagnostics Limited
Blue Earth Diagnostics Limited
Representantes
Boris Umansky Ladas & Parry LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemical preparations for use in scientific research; diagnostic chemicals for scientific use; Positron Emission Tomography (PET) imaging tracing chemicals for scientific and laboratory use; synthetic proteins and amino acids for use in Positron Emission Tomography (PET) imaging for laboratory and research use; reagents for use in Positron Emission Tomography (PET) imaging for laboratory and research use; diagnostic scanning agents for in-vivo use for medical research use ; diagnostic scanning agents for in-vivo use for scientific or research use; chemicals for use in molecular imaging for scientific or research use
Classe 5
Diagnostic preparations for medical purposes; medical preparations in the nature of contrast agentsmolecular imaging agentsradiopharmaceuticalsPET agentsradiotracersPET tracers and diagnostic imaging agents for use in medical imaging; Positron Emission Tomography (PET) tracing chemicals for medical use; PET tracing chemicals and reagents prepared for ingestion or injection into humans and animals for medical use; diagnostic chemicals for medical purposes; reagents for medical purposes; diagnostic scanning agents for medical use; preparations for use in medical imagingcontrast agentsmolecular imaging agentsradiopharmaceuticalsPET agentsradiotracersPET tracers and diagnostic imaging agents for use with imaging medical equipment; contrast agents for use in medical imaging and molecular imaging; amino acids for use in medical imaging
Classe 42
scientific and medical research and product design in relation to Positron Emission Tomography (PET) imaging; medical and scientific research in relation to disease diagnosis; scientific and medical research in relation to molecular imaging; development of molecular imaging productsdevelopment of non-medical molecular imaging services; diagnostic imaging for scientific purposes; scientific imaging services; medical laboratory services ; medical and pharmacological research services ; scientific consultancy in relation to the aforesaid services
Classe 44
Medical services; Positron Emission Tomography (PET) medical imaging services; medical imaging services; medical services in the diagnosis of conditions in the body; providing medical consultancy in relation to the aforesaid services ; development of medical molecular imaging services
Publicações
Histórico de despachos e eventos da marca no USPTO.
30 publicações encontradas
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
07/05/2026
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
07/05/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/05/2026
E89R
TEAS SECTION 8 & 9 RECEIVED
03/03/2026
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
29/03/2025
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
31/03/2023
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
31/03/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
31/03/2023
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
21/10/2022
E815
TEAS SECTION 8 & 15 RECEIVED
21/09/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
29/03/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
23/08/2018
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
23/08/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
29/03/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/01/2016
PUBO
PUBLISHED FOR OPPOSITION
12/01/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
24/12/2015
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
07/12/2015
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
04/12/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
16/11/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
16/11/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
16/11/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
16/11/2015
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
27/05/2015
GNRT
NON-FINAL ACTION E-MAILED
27/05/2015
CNRT
NON-FINAL ACTION WRITTEN
27/05/2015
DOCK
ASSIGNED TO EXAMINER
26/05/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/03/2015
NWAP
NEW APPLICATION ENTERED
21/02/2015
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace BLUE EARTH ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.